Logotipo do repositório
 

Publicação:
From dermatological conditions to COVID-19: Reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy

Página do item simplificado
dc.contributor.authorCriado, Paulo Ricardo
dc.contributor.authorMiot, Hélio Amante [UNESP]
dc.contributor.authorPincelli, Thais Prota Hussein
dc.contributor.authorFabro, Alexandre Todorovic
dc.contributor.institutionCentro Universitário Saúde ABC
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionMayo Clinic
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.date.accessioned2021-06-25T10:45:42Z
dc.date.available2021-06-25T10:45:42Z
dc.date.issued2021-01-01
dc.description.abstractCOVID-19 generates a complex systemic inflammatory response that can lead to death due to wide macrophage activation, endothelial damage, and coagulation in critically ill patients. SARS-CoV-2-induced lung injury due to inflammatory mediated thrombosis could be similar to the livedoid vasculopathy in the skin, supporting a translational comparison of these clinical settings. In this article, we discuss anticoagulation, suppression of inflammatory response, and hyperbaric oxygen therapy in the context of severe COVID-19 and livedoid vasculopathy.en
dc.description.affiliationDepartment of Dermatology Centro Universitário Saúde ABC
dc.description.affiliationDepartment of Dermatology and Radiotherapy Faculdade de Medicina da Unesp
dc.description.affiliationDepartment of Dermatology Mayo Clinic
dc.description.affiliationDepartment of Pathology and Forensic Medicine Faculdade de Medicina de Ribeirão Preto da USP
dc.description.affiliationUnespDepartment of Dermatology and Radiotherapy Faculdade de Medicina da Unesp
dc.identifierhttp://dx.doi.org/10.1111/dth.14565
dc.identifier.citationDermatologic Therapy, v. 34, n. 1, 2021.
dc.identifier.doi10.1111/dth.14565
dc.identifier.issn1529-8019
dc.identifier.issn1396-0296
dc.identifier.scopus2-s2.0-85096931294
dc.identifier.urihttp://hdl.handle.net/11449/206901
dc.language.isoeng
dc.relation.ispartofDermatologic Therapy
dc.sourceScopus
dc.subjectCOVID-19
dc.subjectheparin
dc.subjecthyperbaric oxygenation
dc.subjectlivedoid
dc.subjectthrombosis
dc.subjectvasculopathy
dc.titleFrom dermatological conditions to COVID-19: Reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapyen
dc.typeResenha
dspace.entity.typePublication
unesp.author.orcid0000-0001-9785-6099[1]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt
unesp.departmentDermatologia e Radioterapia - FMBpt

Arquivos

Coleções

Botucatu - FMB - Faculdade de Medicina